Investment Action - Clarivate Plc (NYSE: CLVT) is recommended as a buy due to expected organic growth recovery as the macro environment improves, with no structural weaknesses identified in the business [2] - The organic growth recovery story remains intact, with improvements noted in the two largest segments [2] Earnings Review - In Q2 2024, CLVT reported a revenue decline of 2.8% on a reported basis and 0.6% on an organic basis, with transactional revenue down 4.1% and subscription revenue up 0.7% year-over-year [3] - EBITDA margin contracted by 40bps to 42.2%, but EPS exceeded consensus expectations at $0.20 compared to $0.18 [3] - Organic growth improved from -1.7% in Q1 2024 to -0.6% in Q2 2024, driven by the Academia & Government (A&G) and Intellectual Property (IP) segments [3] Segment Performance - A&G segment organic growth accelerated from 0.6% in Q1 2024 to 1.3% in Q2 2024, with subscription revenue growing over 3% and renewal rates exceeding 96% [3] - IP segment organic growth improved from -4.5% in Q1 2024 to -1.8% in Q2 2024, indicating stabilizing trends in trademark search volumes [3] - Life Sciences & Healthcare (LS&H) segment saw a decline in organic growth from 2.8% to 3.9%, attributed to a weak macro environment affecting large pharma budgets [5] Market Outlook - The long-term trend indicates that R&D expenditure typically increases over time, suggesting a potential recovery following the current macro downturn [5] - Expectations for a strong recovery in the LS&H segment by FY25 as pharma companies resume R&D initiatives [5] Valuation - Current valuation at 6.5x forward PE is considered cheap, with potential upside if growth accelerates to 3% by FY26 and margins improve to 22% [7] - Historical margins ranged between 23-25% from FY20 to FY23, with a target of 22% by FY26 [9] Key Takeaways - A&G segment is expected to return to historical low single-digit growth rates as the macro environment improves [8] - IP segment is likely to continue its organic growth improvement as CLVT gains market share [8] - Recovery timing for the LS&H segment is contingent on macroeconomic recovery, anticipated by FY25 [8]

LONDON, Aug. 7, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today that Jonathan Collins, Executive Vice President and Chief Financial Officer, will present at the Oppenheimer 27th Annual Technology, Internet & Communications Virtual Conference, on Monday, August 12, 2024 at 2:55 pm Eastern Time. The live webcast can be accessed at https://wsw.com/webcast/oppenheimer37/clvt/2805750 and will be available for replay. A replay of each webc ...

Group 1 - Clarivate Plc, a leading global provider of transformative intelligence, will have its Executive Vice President and Chief Financial Officer, Jonathan Collins, present at the Oppenheimer 27th Annual Technology, Internet & Communications Virtual Conference on August 12, 2024 [1] - The live webcast of the presentation can be accessed online and will be available for replay [1][2] - Clarivate offers enriched data, insights, analytics, workflow solutions, and expert services across various sectors including Academia & Government, Intellectual Property, and Life Sciences & Healthcare [3]

Clarivate Plc (NYSE:CLVT) Q2 2024 Earnings Conference Call August 6, 2024 9:00 AM ET Company Participants Mark Donohue - Vice President of Investor Relations Andrew Snyder - Chairman of the Board Jonathan Gear - Chief Executive Officer, Matti Shem Tov - Jonathan Collins - Chief Financial Officer Conference Call Participants Toni Kaplan - Morgan Stanley Manav Patnaik - Barclays Surinder Thind - Jefferies Shlomo Rosenbaum - Stifel Wahid Amin - Bank of America Owen Lau - Oppenheimer Andrew Nicholas - William ...

Core Insights - Clarivate PLC (CLVT) reported revenue of $650.3 million for the quarter ended June 2024, reflecting a year-over-year decline of 2.8% and an EPS of $0.20, down from $0.21 a year ago [1] - The revenue fell short of the Zacks Consensus Estimate of $653.29 million by 0.46%, while the EPS exceeded the consensus estimate of $0.18 by 11.11% [1] Revenue Breakdown - Intellectual Property revenues were $201.60 million, surpassing the average estimate of $199.95 million, but showing a year-over-year decline of 6.8% [3] - Life Sciences & Healthcare revenues totaled $104.20 million, below the average estimate of $107.80 million, marking a year-over-year decrease of 5.7% [4] - Academia & Government revenues reached $344.50 million, exceeding the average estimate of $336.67 million, with a slight year-over-year increase of 0.7% [5] - Transactional and other revenues amounted to $136.10 million, surpassing the average estimate of $120.74 million, but reflecting a year-over-year decline of 10.3% [6] - Re-occurring revenues were reported at $108.60 million, below the average estimate of $111.58 million, indicating a year-over-year decrease of 2.2% [7] - Subscription revenues were $405.60 million, falling short of the average estimate of $420.73 million, with a minimal year-over-year change of -0.1% [8] Stock Performance - Clarivate's shares have returned +9.6% over the past month, contrasting with the Zacks S&P 500 composite's decline of -6.7% [8] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [8]

Clarivate PLC (CLVT) came out with quarterly earnings of $0.20 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.21 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 11.11%. A quarter ago, it was expected that this company would post earnings of $0.14 per share when it actually produced earnings of $0.14, delivering no surprise. Over the last four quarters, the company has surpa ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Ordinary Shares, no par value CLVT New York Stock Exchange Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to _______ Commission Fi ...

Clarivate Reports Second Quarter 2024 Results — Reaffirms 2024 Outlook — London, UK -- August 6, 2024 Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial Highlights • Revenues of $650.3 million decreased 2.8% • Organic revenues decreased 0.6%, as an increase in subscription revenues of 0.7% was offset by a decrease in reoccurring revenues of 0.7% a ...

Leadership Transition - Clarivate Plc announced the appointment of Matti Shem Tov as the new CEO, effective August 9, 2024, succeeding Jonathan Gear, who will transition to a non-executive role until November 1, 2024 [1][2] - The Board and Jonathan Gear mutually agreed that new leadership is necessary for the next phase of Clarivate's value creation journey [2] Contributions and Achievements - Under Jonathan Gear's leadership, Clarivate restructured into three end-market segments, enhancing product innovation investments and customer commitment [2] - The restructuring has strengthened the company's balance sheet and positioned Clarivate to deliver tailored solutions globally [2] New CEO's Background - Matti Shem Tov has over 30 years of global leadership experience in software, data, and analytics, with a focus on driving innovation and growth [4] - He previously served as CEO of ProQuest and has held leadership roles in various companies, including Ex Libris and Surecomp [4] Future Outlook - Matti Shem Tov expressed his commitment to accelerating growth, increasing product innovation, and driving value creation for stakeholders [2][4] - The Board is confident that Shem Tov's expertise will help launch Clarivate into a new phase of accelerated organic growth [2]

— Reaffirms 2024 Outlook — LONDON, Aug. 6, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial Highlights Revenues of $650.3 million decreased 2.8% Organic revenues decreased 0.6%, as an increase in subscription revenues of 0.7% was offset by a decrease in re-occurring revenues of 0.7% and transactional and other revenues of 4. ...